Presentation: Repurposed drugs in Covid-19: Ivermectin
A reminder of the presentation given to Scientific Conference of the Royal College of Emergency Medicine on 6 October 2021 The talk was given by:
Please bookmark this page and visit regularly to find the latest Protocols, Evidence, Trials and more to show how ivermectin can be used successfully.
A reminder of the presentation given to Scientific Conference of the Royal College of Emergency Medicine on 6 October 2021 The talk was given by:
Australian Phillip Altman BPharm (Hons), MSc, PhD gives his detailed comparison of ivermectin and Molnupiravir which Merck is developing as an oral treatment for covid.
Prophylactic Role of Ivermectin in Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers Behara, Patro et al. Two doses of oral ivermectin (300
Martin Neil and Norman Elliot Fenton et al. Queen Mary, University of London. PAMBAYESIAN (PAtient Managed decision-support using Bayesian networks) A new analysis from Queen
Download the letter Robert T. Schooley, MD, Editor-in-Chief Clinical Infectious Diseases198 Madison AveNew York NY 10016 USA Dear Dr Schooley Open Letter Statement of Concern and
New RCT article published in Asian Pacific Journal of Tropical Medicine. Niaee, Namdar et al. Concludes that Ivermectin as an adjunct reduces the rate of
Journal Published Peer-reviewed Systematic Review, Meta analysis and Trial Sequential Analysis of 15 trials informs clinical guidelines that safe medicine ivermectin definitely works to reduce
Doctors for Life in Brazil SUPPORT BIRD’S position and conclusions that contradict the WHO and show there is MUCH evidence to recommend Ivermectin for COVID-19,
Join global medical experts as they share the latest research, thoughts and insights on the ivermectin for covid-19 solution. Click here to register TODAY! Date:
The I-MASS protocol has been developed for Mass Distribution during regional outbreaks or in resource poor countries to lessen the impact and spread of COVID-19.
Developed and Updated by Paul Marik, MD, FCP (SA), FRCP (C), FCCP, FCCM for the COVID-19 Critical Care Alliance (FLCCC Alliance). FLCCC’s recommended approach to
An overview of the MATH+, I-MASK+ and I-RECOVER Protocols A Guide to the Management of COVID-19 Developed and Updated by Paul Marik, MD, FCP (SA), FRCP
Kory, Pierre MD; Meduri, Gianfranco Umberto MD; Varon, Joseph MD; Iglesias, Jose DO; Marik, Paul E. MDPublished May 2021 in the American Journal of Therapeutics.
FLCCC: Front Line COVID-19 Critical Care Alliance:
The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Their MATH+ Hospital Treatment Protocol, introduced in March 2020, has saved thousands of patients who were critically ill with COVID-19. Now, the FLCCC’s new I-MASK+ Prophylaxis and Early At-Home Outpatient Treatment Protocol with Ivermectin has been released – and is a potential solution to the global pandemic. Visit>>
IVMmeta
This site provides real-time meta analysis of 50+ studies conducted across the world on ivermectin for covid-19. Visit>>
The team at Bird are transparent in our operations. Bird is a campaign managed through EbMCsquared, a not-for-profit Community Interest Company. It means 100% of profits after tax are reinvested into the business or to the advancement of our social purpose, for example to work on projects such as the Ivermectin campaign. We are here to promote and provide evidence for health and wellbeing, to inform decision-making on matters of public health and safety. We do this to advance health and wellbeing for the benefit of humankind.
Nothing on this Website provides medical advice or any form of diagnosis or treatment of any kind to web users. Medical decisions should be made by the patient’s physician who can consider a review of the BIRD materials and knowledge of the patient’s medical history and condition. All information provided on the BIRD website or in connection with the Website are offered to promote consideration by trained health care professionals of possible treatments and for general informational purposes and are not medical advice to users. Errors and Omissions excepted.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Please support our campaign with a monthly or a single amount to help us keep pressure on authorities to approve the safe drug ivermectin that will help beat covid-19 and save lives around the world.
Bird Group/EBMC Squared is a not-for-profit Community Interest Company (CIC).
All funds received will be invested in our activities to promote public health and wellbeing.
Your monthly or single contribution will help us keep pressure on authorities to approve the safe drug ivermectin that will help beat covid-19 and save lives around the world.